Esther Rajavelu
Stock Analyst at UBS
(0.59)
# 3,732
Out of 4,789 analysts
27
Total ratings
40%
Success rate
-25.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.46 | +334.69% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $12.29 | +160.37% | 2 | Apr 9, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $141 → $215 | $255.76 | -15.94% | 5 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $33.84 | +115.72% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $22.60 | +382.30% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $6.23 | +461.80% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $27.26 | +37.56% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $124.99 | +82.41% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $1.13 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $12.21 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $17.94 | -27.54% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.98 | +920.41% | 1 | Jul 21, 2017 |
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.46
Upside: +334.69%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $12.29
Upside: +160.37%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141 → $215
Current: $255.76
Upside: -15.94%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $33.84
Upside: +115.72%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $22.60
Upside: +382.30%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $6.23
Upside: +461.80%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $27.26
Upside: +37.56%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $124.99
Upside: +82.41%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $1.13
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $12.21
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $17.94
Upside: -27.54%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $0.98
Upside: +920.41%